Sublobar Resection Versus Lobectomy for Stage IA Non-Small Cell Lung Carcinoma—Takeaways From Modern Randomized Trials

May 23, 2024

Submitted by: Jo Chikwe

Source: The Annals of Thoracic Surgery

Source URL: https://www.annalsthoracicsurgery.org/article/S0003-4975(24)00001-8/abstract

Keywords:

Thoracic

Author(s): Peter J. Kneuertz, Dana Ferrari-Light, Nasser K. Altorki

Sublobar resection for early-stage non-small cell lung cancer has recently been compared with lobectomy in three randomized trials. This expert review summarizes and compares these three landmark trials and describes how these new data inform best practice.

Add Comments Cancel reply

You must be logged in to post a comment.

2026 Instructional Video Competition Winners

welcomes you to the new, improved website!

Sublobar Resection Versus Lobectomy for Stage IA Non-Small Cell Lung Carcinoma—Takeaways From Modern Randomized Trials

Add Comments Cancel reply

Related Content

The Beat With Joel Dunning Ep. 160: Shifting Healthcare Policy in Surgery

Ethical Leadership in Cardiothoracic Surgery in an Era of Consolidation: A Framework for Trust, Transparency, and Workforce Stability

Robotic Resection of a Giant Superior Mediastinal Mass

Evaluation and Management of N2+ Non-Small Cell Lung Cancer: An Interview With Dr. Philip Linden

Single-Port Robotic Platforms: An Interview With Dr. Diego Gonzalez Rivas

SCTS 2026 | Surgery on the Thymus Gland

The Beat With Joel Dunning Ep. 159: Aortic Root Enlargement

FILONEX—A Prospective, Randomized Controlled Pilot Safety Study Evaluating the Addition of Hemodiafiltration to EVLP in Marginal Donor Lungs

Outcomes of Lung Transplantation Surgery Performed at Night

RATS Extended Left Upper Lobectomy With Intrapericardial Vascular Control and Bronchoplasty: An Interview With Dr. Filipe Azenha